← Leaderboards
Gerald J Gleich
Mayo Clinic Coll Of Medicine, Rochester
$5,484,106
Attributed
$5,763,955
Total exposure
20
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $767.9K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$6,553,860 · 21
By mechanism
R01$3,747,398 · 2
U19$939,755 · 2
R43$590,578 · 1
R21$411,618 · 1
U44$299,982 · 1
T32$299,502 · 1
Top collaborators
- David D Eckels2 shared
- Lori A Wagner2 shared
Others in their field
Top investigators on “Eosinophil”
- Marc E. Rothenberg · Cincinnati Childrens Hosp Med Ctr$44,428,890
- Joshua A Boyce · Brigham And Women'S Hospital$23,179,588
- Hirohito Kita · Mayo Clinic Arizona$21,211,797
- Nizar N Jarjour · University Of Wisconsin Madison$19,170,779
- David H Broide · University Of California, San Diego$17,873,137
- Peter F Weller · Boston University Medical Campus$17,472,817
Research focus
EosinophilEosinophiliaClinical ResearchHuman SubjectGranuleImmuneProtein PurificationBlood ProteinsProteinsResearch PersonnelGrantAllergicEnzyme ActivityLaboratory RabbitInstitutionBone MarrowInterleukin 5ProductionInterleukin-5Protein Structure FunctionCellsCysteine EndopeptidasesTissuesFunding
Grant awards (37)
Development of a Treatment for Eosinophil-Mediated Allergic Inflammatory Diseases Utilizing a Neutralizing Agent Targeting Eosinophil Granule Major Basic Protein$290,732
R43 · FY2022 · AI · contact PI
Development of a Treatment for Eosinophil-Mediated Allergic Inflammatory Diseases Utilizing a Neutralizing Agent Targeting Eosinophil Granule Major Basic Protein$299,846
R43 · FY2021 · AI · contact PI
Novel, Non-InvasiveImaging of Eosinophil-Related Inflammation Throughout the Esophagus in Patients withEosinophilic Esophagitis$299,982
U44 · FY2020 · AI · contact PI
TMEM103 in Eosinophil Development$223,493
R21 · FY2010 · AI
TMEM103 in Eosinophil Development$188,125
R21 · FY2009 · AI
T Cell Reactive Epitopes of Shrimp Tropomyosin$73,330
R03 · FY2008 · AI · contact PI
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB$3,696
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA$1,633
M01 · FY2008 · RR · contact PI
STANDARD VALUES OF EOSINOPHIL-RELATED PARAMETERS FOR DATA COMPARISON$430
M01 · FY2008 · RR · contact PI
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB$321,059
R01 · FY2007 · AI · contact PI
T Cell Reactive Epitopes of Shrimp Tropomyosin$74,750
R03 · FY2007 · AI · contact PI
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB$23,544
M01 · FY2007 · RR · contact PI
ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA$10,403
M01 · FY2007 · RR · contact PI
STANDARD VALUES OF EOSINOPHIL-RELATED PARAMETERS FOR DATA COMPARISON$2,738
M01 · FY2007 · RR · contact PI
Eosinophil Granule Proteins and Their Functions$394,223
R01 · FY2006 · AI · contact PI
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB$330,648
R01 · FY2006 · AI · contact PI
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB$24,520
M01 · FY2006 · RR · contact PI
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB - OPEN LABEL$18,505
M01 · FY2006 · RR · contact PI
Eosinophil Granule Proteins and Their Functions$394,847
R01 · FY2005 · AI
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB$338,605
R01 · FY2005 · AI
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB$26,427
M01 · FY2005 · RR
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB - OPEN LABEL$4,615
M01 · FY2005 · RR
Eosinophil Granule Proteins and Their Functions$386,244
R01 · FY2004 · AI
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB$363,355
R01 · FY2004 · AI
Eosinophilia myalgia syndrome$436
M01 · FY2004 · RR
Eosinophil Granule Proteins and Their Functions$377,914
R01 · FY2003 · AI
Eosinophil Granule Proteins and Their Functions$193,519
R01 · FY2002 · AI
Core--eosinophil granule protein laboratory$0
P01 · FY2002 · AI
EOSINOPHIL AND BASOPHIL GRANULE PROTEINS$253,078
R01 · FY2001 · AI
TRAINING GRANT IN ALLERGIC DISEASES$160,412
T32 · FY2001 · AI
EOSINOPHIL AND BASOPHIL GRANULE PROTEINS$85,400
R01 · FY2001 · AI
Core--eosinophil granule protein laboratory$0
P01 · FY2001 · AI
MECHANISMS OF EOSINOPHIL ASSOCIATED INFLAMATION$789,905
U19 · FY2000 · AI
EOSINOPHIL AND BASOPHIL GRANULE PROTEINS$287,136
R01 · FY2000 · AI
LIDOCAINE AND SULFONYLUREAS AS GLUCOCORTICOMIMETIC AGENTS$149,850
U19 · FY2000 · AI
TRAINING GRANT IN ALLERGIC DISEASES$139,090
T32 · FY2000 · AI
EOSINOPHIL AND BASOPHIL GRANULE PROTEINS$21,370
R01 · FY2000 · AI